- Report
- April 2022
- 307 Pages
Global
From €4861EUR$5,550USD£4,219GBP
- Book
- May 2019
North America
The Platelet Disorder market is a subset of the Hematology market, which focuses on the study of blood and blood-forming organs. Platelet Disorders are a group of conditions that affect the production, function, and lifespan of platelets, which are a type of blood cell responsible for clotting. Platelet Disorders can be caused by a variety of factors, including genetic mutations, autoimmune diseases, and certain medications. Symptoms of Platelet Disorders can range from mild to severe, and can include excessive bleeding, bruising, and fatigue. Treatment options for Platelet Disorders vary depending on the cause and severity of the condition, and may include medications, lifestyle changes, and blood transfusions.
Companies in the Platelet Disorder market include Novartis, Pfizer, Bayer, and Shire. Show Less Read more